Table 1.
NAFLD-associated HCC epidemiology and burden
| Country | Incidence and prevalence | Population | Study period | Ref. |
|---|---|---|---|---|
| United States | 0.21 per 1000 person-years | Veterans Affairs | 2003-2011 | Kanwal et al.[22] |
| 14.1% of all cases | SEER registries | 2004-2009 | Younossi et al.[136] | |
| 8% of all HCC cases | Veterans Affairs | 2005-2011 | Mittal et al.[23] | |
| 1.56% of HCC cases | Veterans Affairs | 2012-2018 | Ioannou et al.[24] | |
| 5.29 per 1000 person-years | Meta-analysis | 1989-2015 | Younossi et al.[3] | |
| 13.5% of all liver transplants | United Network Organ for Sharing | 2000-2012 | Wong et al.[26] | |
| Spain, Italy, the Netherlands, United Kingdom | 0.3 per 1000 person-years | European primary care databases | 2016 | Alexander et al.[30] |
| United Kingdom | 35% of all HCC referrals | National Health Services | 2010 | Dyson et al.[137] |
| Japan | 6% incidence | Single hospital in Tokyo | 1994-2007 | Arase et al.[138] |
| South Korea | 12.2% incidence | South Korean hospital | 2006-2010 | Cho et al.[34] |
NAFLD: nonalcoholic fatty liver disease; HCC: hepatocellular carcinoma; SEER: surveillance, epidemiology and end results